NeuroCME

This activity is expired and is no longer available for CME credit.

EXPERT INTERVIEWVIDEOCME

Risk vs Benefit in Implementing Natalizumab

Author(s)/Faculty: Bruce A. Cohen, MD
Release Date: 12/30/2013Expiration Date: 11/12/2016
Credit Type: CMENumber of Credits: 0
Content Type: MultimediaProvider:
Dr. Bruce Cohen discusses the appropriate implementation and utilization of natalizumab in patients with MS.